Document is current
Any future updates will be listed below
-
Authors
Mahlknecht, Angelika https://orcid.org/0000-0002-5280-5447
Krisch, Laura
Nestler, Nadja
Bauer, Ulrike
Letz, Nina
Zenz, Daniel
Schuler, Jochen
Fährmann, Laura
Hempel, Georg
Flamm, Maria
Osterbrink, Jürgen
-
Funding
Funding for this research was provided by:
Grünenthal GmbH Germany
City of Münster, Germany
Local Government of Salzburg, Austria
- License Information
-
More Information
Article History
Received: 4 September 2018
Accepted: 29 August 2019
First Online: 18 September 2019
Ethics approval and consent to participate
: All study participants were informed in detail about the study and signed informed consent according to the Declaration of Helsinki. The study protocol was registered on 2015-09-02 via the German Clinical Trials Register (ID: DRKS00007900, available also on the Meta-registry of the WHO); due to bureaucratic delays, registration was completed 4 months after obtaining the first written consent and 6 weeks after commencement of the first data collection.Ethical approval was obtained from the responsible Ethics Committee (Ethics Committee of the Medical Association Westphalia-Lippe and of the Faculty of Medicine of the University of Muenster) on 2015-03-27 (approval number 2015–147-f-S).
: Not applicable.
: NN: In the last 5 years I have received lecture honoraria from Grünenthal and Mundipharma.GH: In the last 5 years I have received lecture honoraria from Grünenthal.JO: In the last 5 years I have received lecture honoraria from Pfizer, Grünenthal and Mundipharma.All other authors declare to have no competing interests.
